Evidence map›Paper›PMID 31812658›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2021

Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men.

Monika Sarkar, Katherine Yates, Ayako Suzuki, Joel Lavine, Ryan Gill, Toni Ziegler, Norah Terrault, Sandeep Dhindsa

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06124261 (Androgens and Nonalcoholic Fatty Liver Disease), which is not on this map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06124261 recruitingnot on this mapstarted 2024, after this paper: background citation

Androgens and Nonalcoholic Fatty Liver Disease (NAFLD) In Reproductive-Aged Women With and Without Polycystic Ovary Syndrome (PCOS)

Typeobservational_patient_registrySponsorUniversity of California, San FranciscoRan2024 to 2028Enrolled150ConditionsPCOS, NAFLD, NASH
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Hepatic immune regulation and sex disparities.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Monika SarkarDivision of Gastroenterology and Hepatology, University of California, San Francisco, San Francisco, California. Electronic address: monika.sarkar@ucsf.edu.
Katherine YatesDepartment of Biostats and Epidemiology, Johns Hopkins University, Baltimore, Maryland.
Ayako SuzukiDivision of Gastroenterology and Hepatology, Duke University, Durham, North Carolina.
Joel LavineDivision of Pediatric Gastroenterology and Hepatology, Columbia University, New York, New York.
Ryan GillDepartment of Pathology, University of California, San Francisco, San Francisco, California.
Toni ZieglerNational Primate Research Center, University of Wisconsin, Madison, Wisconsin.
Norah TerraultDivision of Gastroenterology and Hepatology, University of California, San Francisco, San Francisco, California; Division of Gastroenterology and Hepatology, University of Southern California, Los Angeles, California.
Sandeep DhindsaDivision of Endocrinology and Metabolism, Saint Louis University, Saint Louis, Missouri.

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
VEDS Year2-Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating CenterU24DK061730 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI JEANNE M CLARK, David M Shade · 2019 to 2026
$11.3M
Pathogenesis, prognosis, and treatment of NAFLD patientsU01DK061713 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ANNA MAE ELIZABETH DIEHL · 2002 to 2026
$10.3M
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)U01DK061738 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Norah A. Terrault · 2002 to 2026
$8.9M
Androgens and Nonalcoholic Steatohepatitis: The Role of Male Sex Hormones in Women with NASHK23DK111944 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SARKAR, MONIKA · 2017 to 2021
$1.2M
NIDDK NIH HHS K23 DK111944NIDDK NIH HHS P30 DK026743NIDDK NIH HHS U01 DK061713NIDDK NIH HHS U01 DK061738NIDDK NIH HHS U24 DK061730
6 · The paper itself

Abstract

With rising prevalence of obesity and diabetes, nonalcoholic fatty liver disease (NAFLD) is now a leading cause of chronic liver disease. One-third of obese or diabetic men have subnormal free and bioavailable testosterone concentrations.

Indexed as

Non-alcoholic Fatty Liver DiseaseFibrosisHumansLiverMaleObesityTestosteroneTestosterone

Identifiers

PMID31812658
PMCPMC7272262

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.